Tue, February 14, 2023

Robert Wasserman Maintained (ANEB) at Buy with Decreased Target to $8 on, Feb 14th, 2023

Robert Wasserman of Benchmark, Maintained "Anebulo Pharmaceuticals, Inc." (ANEB) at Buy with Decreased Target from $10 to $8 on, Feb 14th, 2023.

Robert, nor any peers, have made any analyst calls on ANEB in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30